These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38265001)

  • 1. Development and Validation of MRI Radiomics Models to Differentiate HER2-Zero, -Low, and -Positive Breast Cancer.
    Peng Y; Zhang X; Qiu Y; Li B; Yang Z; Huang J; Lin J; Zheng C; Hu L; Shen J
    AJR Am J Roentgenol; 2024 Apr; 222(4):e2330603. PubMed ID: 38265001
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
    Eur Radiol; 2024 Sep; 34(9):6132-6144. PubMed ID: 38363315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
    Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
    J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers.
    Ramtohul T; Djerroudi L; Lissavalid E; Nhy C; Redon L; Ikni L; Djelouah M; Journo G; Menet E; Cabel L; Malhaire C; Tardivon A
    Radiology; 2023 Aug; 308(2):e222646. PubMed ID: 37526540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI-based radiomics nomogram for predicting the hormone receptor status of HER2-positive breast cancer.
    Sang L; Liu Z; Huang C; Xu J; Wang H
    Clin Radiol; 2024 Jan; 79(1):60-66. PubMed ID: 37838543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI Radiomics With Machine Learning for Differentiating HER2-Zero, -Low, and -Positive Breast Cancer: Model Development, Testing, and Interpretability Analysis.
    Chen Y; Chen S; Tang W; Kong Q; Zhong Z; Yu X; Sui Y; Hu W; Jiang X; Guo Y
    AJR Am J Roentgenol; 2024 Oct; ():. PubMed ID: 39413232
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiomics Nomogram Based on Dual-Sequence MRI for Assessing Ki-67 Expression in Breast Cancer.
    Zhang L; Shen M; Zhang D; He X; Du Q; Liu N; Huang X
    J Magn Reson Imaging; 2024 Sep; 60(3):1203-1212. PubMed ID: 38088478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
    Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
    Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
    BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
    Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
    Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
    Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning models for differential diagnosing HER2-low breast cancer: A radiomics approach.
    Chen X; Li M; Su D
    Medicine (Baltimore); 2024 Aug; 103(33):e39343. PubMed ID: 39151526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer.
    Braman N; Prasanna P; Whitney J; Singh S; Beig N; Etesami M; Bates DDB; Gallagher K; Bloch BN; Vulchi M; Turk P; Bera K; Abraham J; Sikov WM; Somlo G; Harris LN; Gilmore H; Plecha D; Varadan V; Madabhushi A
    JAMA Netw Open; 2019 Apr; 2(4):e192561. PubMed ID: 31002322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
    Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
    Front Oncol; 2021; 11():706733. PubMed ID: 34490107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.
    Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J
    J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.
    Zhang J; Wang G; Ren J; Yang Z; Li D; Cui Y; Yang X
    Eur Radiol; 2022 Jun; 32(6):4079-4089. PubMed ID: 35050415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2-Positive Breast Cancer: Association of MRI and Clinicopathologic Features With Tumor-Infiltrating Lymphocytes.
    Lee HJ; Lee JE; Jeong WG; Ki SY; Park MH; Lee JS; Nah YK; Lim HS
    AJR Am J Roentgenol; 2022 Feb; 218(2):258-269. PubMed ID: 34431365
    [No Abstract]   [Full Text] [Related]  

  • 20. The Emergence of the Potential Therapeutic Targets: Ultrasound-Based Radiomics in the Prediction of Human Epidermal Growth Factor Receptor 2-Low Breast Cancer.
    Du Y; Li F; Zhang M; Pan J; Wu T; Zheng Y; Chen J; Yao M; Kuang Y; Wu R; Diao X
    Acad Radiol; 2024 Jul; 31(7):2674-2683. PubMed ID: 38309977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.